Yvonne Döring

The paper identifies D6PV, a peptide that enhances remyelination by boosting oxidative phosphorylation in oligodendrocytes without affecting immune responses.

This study shows that neural CXCR4 reduces atherosclerotic plaque formation in mice without affecting metabolism or immune cells, and identifies MIF-CXCR4 signaling in the PVN as a potential neuroimmune pathway in atherosclerosis.

This study shows that Galectin-1 reduces atherosclerotic plaque formation by reprogramming macrophages and modulating T cell immunity through both glycan-dependent and -independent mechanisms.

This study shows cigarette smoke increases vascular ADAMTS7 expression through CCL17-CCR4 signaling, linking smoking to atherosclerosis via a novel gene-environment interaction.

This study shows that gut microbial metabolite imidazole propionate impairs endothelial function and promotes atherosclerosis in both human and animal models.

This study identifies the Nfe2l1-Atf3 pathway as a regulator of cholesterol-induced adipocyte inflammation and insulin resistance in both human and mouse models.

This paper shows that miR-26b deficiency worsens MASH in mice, and that miR-26b mimic-loaded LNPs can reverse these effects.

WEGS combines low-depth whole genome and high-depth whole exome sequencing to reduce costs while maintaining variant detection accuracy in genetic studies.